Protalix BioTherapeutics (PLX) EBIT Margin (2009 - 2026)
Protalix BioTherapeutics' EBIT Margin was 23.48% in Q2 2026, up 16.00 percentage points from 7.48% a year earlier but down 39.17 percentage points from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) EBIT Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Protalix BioTherapeutics' EBIT Margin was 28.89% through Jun 30, 2026, up 15.61 percentage points year-over-year; for FY2025, it was -10.43%, down 17.76 percentage points from FY2024.
- EBIT Margin shows a five-year change of -14.74 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was 7.34% in FY2024 (-8.64 pp), 15.97% in FY2023 (+43.29 pp), -27.32% in FY2022 (+26.04 pp) and -53.36% in FY2021 (-57.66 pp).
- Quarterly EBIT Margin has moved between -129.56% (Q1 2024) and 62.65% (Q1 2026) over five years.
- Compared with a year earlier, EBIT Margin was higher in six of the last eight quarters, with an average year-over-year change of +33.30 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q2 2023 (a gain of 121.33 percentage points); the worst was Q1 2024 (a drop of 103.92 percentage points).
- Per Business Quant data, PLX's EBIT Margin in the three quarters before Q2 2026 was 62.65% (Q1 2026), -51.06% (Q4 2025) and 11.94% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Protalix BioTherapeutics | 230.43 Mn | 59.88 Mn | 14.05 Mn | 18.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18.46% |
| Jun 30, 2026 | 23.48% |
| Mar 31, 2026 | 62.65% |
| Dec 31, 2025 | -51.06% |
| Sep 30, 2025 | 11.94% |
| Jun 30, 2025 | 7.48% |
| Mar 31, 2025 | -40.99% |
| Dec 31, 2024 | 39.57% |
| Sep 30, 2024 | 22.22% |
| Jun 30, 2024 | -18.01% |
| Mar 31, 2024 | -129.56% |
| Dec 31, 2023 | -53.55% |
| Sep 30, 2023 | -18.24% |
| Jun 30, 2023 | 58.22% |
| Mar 31, 2023 | -25.65% |
| Dec 31, 2022 | -28.95% |
| Sep 30, 2022 | -22.03% |
| Jun 30, 2022 | -63.11% |
| Mar 31, 2022 | -11.63% |
| Dec 31, 2021 | -66.74% |
API Access
Protalix BioTherapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();